Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Gasche

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Clinical Microbiology Reviews|July 12, 2024
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunitiesBernhard Jandl, Satish Dighe, Christoph Gasche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2010
Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeatsChristoph Campregher, Clemens Honeder, Heekyung Chung, et al.
Zeitschrift Fur Gastroenterologie|December 8, 2020
Iron deficiency, depression, and fatigue in inflammatory bowel diseasesPeter König, Kristine Jimenez, Gerda Saletu-Zyhlarz, et al.
Inflammatory Bowel Diseases|January 9, 2015
Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancerVineeta Khare, Kyle Dammann, Mario Asboth, et al.
Gastroenterology|June 14, 2024
Gastrointestinal Biofilms: Endoscopic Detection, Disease Relevance, and Therapeutic StrategiesBernhard Jandl, Satish Dighe, Maximillian Baumgartner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cellsAjay Goel, Dong Kyung Chang, Luigi Ricciardiello, et al.
Biochemical Pharmacology|November 5, 2013
Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cellsVineeta Khare, Michaela Lang, Kyle Dammann, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 13, 2011
Interaction of mesalasine (5-ASA) with translational initiation factors eIF4 partially explains 5-ASA anti-inflammatory and anti-neoplastic activitiesAlex Lyakhovich, Anna Michlmayr, Anastasia Bakulina, et al.
European Journal of Immunology|November 20, 2008
Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1Sabine G Gruber, Maria Gloria Luciani, Paul Grundtner, et al.
Immunogenetics|February 7, 2008
Evolution of Crohn's disease-associated Nod2 mutationsChristoph Gasche, Manuela Nemeth, Paul Grundtner, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Clinical Microbiology Reviews|July 12, 2024
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunitiesBernhard Jandl, Satish Dighe, Christoph Gasche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2010
Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeatsChristoph Campregher, Clemens Honeder, Heekyung Chung, et al.
Zeitschrift Fur Gastroenterologie|December 8, 2020
Iron deficiency, depression, and fatigue in inflammatory bowel diseasesPeter König, Kristine Jimenez, Gerda Saletu-Zyhlarz, et al.
Inflammatory Bowel Diseases|January 9, 2015
Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancerVineeta Khare, Kyle Dammann, Mario Asboth, et al.
Gastroenterology|June 14, 2024
Gastrointestinal Biofilms: Endoscopic Detection, Disease Relevance, and Therapeutic StrategiesBernhard Jandl, Satish Dighe, Maximillian Baumgartner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cellsAjay Goel, Dong Kyung Chang, Luigi Ricciardiello, et al.
Biochemical Pharmacology|November 5, 2013
Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cellsVineeta Khare, Michaela Lang, Kyle Dammann, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 13, 2011
Interaction of mesalasine (5-ASA) with translational initiation factors eIF4 partially explains 5-ASA anti-inflammatory and anti-neoplastic activitiesAlex Lyakhovich, Anna Michlmayr, Anastasia Bakulina, et al.
European Journal of Immunology|November 20, 2008
Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1Sabine G Gruber, Maria Gloria Luciani, Paul Grundtner, et al.
Immunogenetics|February 7, 2008
Evolution of Crohn's disease-associated Nod2 mutationsChristoph Gasche, Manuela Nemeth, Paul Grundtner, et al.
Pageof 11